Shares of Sensyne Health PLC (LON:SENS – Get Free Report) traded down 33.3% during mid-day trading on Wednesday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). 4,449,142 shares traded hands during mid-day trading, an increase of 29% from the average session volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).
Sensyne Health Stock Performance
The stock has a market capitalization of £583,000.00 and a P/E ratio of -0.02. The company has a debt-to-equity ratio of 6.02, a current ratio of 2.26 and a quick ratio of 2.26. The business’s 50 day simple moving average is GBX 0.35 and its 200-day simple moving average is GBX 0.35.
Sensyne Health Company Profile
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.
Further Reading
- Five stocks we like better than Sensyne Health
- Retail Stocks Investing, Explained
- The Cannabis Sector: Profitability Takes Center Stage
- The Most Important Warren Buffett Stock for Investors: His Own
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensyne Health and related companies with MarketBeat.com's FREE daily email newsletter.